Post a Comment Print Share on Facebook


Bayer promotes the confidence of the shareholders

The lesson, the shareholders of the Bayer Board of management have missed, in its place: the critique of the Monsanto Acquisition, the rate of decay and the last of the Non-discharge. The heads are now striving to regain the confidence.

Bayer CEO Werner Baumann is currently not to be envied: The stock price is in the basement, the glyphosate-wave of lawsuits in the United States is getting bigger. Yesterday, the shareholders missed the Bayer Board of management to the annual General meeting, then a lesson and refused to allow him to discharge - something that w as--the Board is yet to happen to any of Dax before.But how to do it now?

After his defeat at the annual General meeting of the Bayer Board of management wants to win back the confidence of shareholders. Wrote the Board members in a letter to employees. The vote was disappointing, but I have no legal effect.

"We understand the mood of our shareholders, and share your disappointment about the course of development of our company," said the Manager. It is understand that the Board will work very hard to have the trust and confidence of the shareholders, to recover.

annual General meeting of the Bayer group: It rained heavy criticism from the shareholders.

a Massive annoyance

Several large shareholders had already announced to vote against the discharge of the Board. The shareholders are upset, especially given the severe losses of the Bayer-share - you lost within a single year, around 40 percent. The group is only 57 billion euros – a little more than they paid for Leverkusen, even for Monsanto. Baumann called this an "excessive rate of reaction". They do not reflect the true value of the company.

Bayer had completed the Monsanto purchase in the past year. In the U.S., more than 13,000 Cancer lawsuits against Monsanto, the result of your diseases on the glyphosate-containing weed killer Roundup. The company was sentenced in two trials to tens of millions of Euro in damages. Bayer denies the allegations and filed an appeal.

Bayer shares lost within one year of approximately 40 percent.

Baumann defended

At the annual General meeting Baumann had defended earlier against the fierce criticism to the Monsanto-Bayer had to fight back against the "unbelievable accusations", he said and stressed again, the weed killer glyphosate is the cancer of the US plaintiff is responsible.

Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.